PATENT CLAIM ANALYSIS

Application Number: 15743486
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "034000"]

Abstract:
Nanoassembled complexes of nucleic acids, avidin and biotinylated compounds functionalized to make them suitable for delivering and releasing drugs are described. These nanoassembled complexes consist of central poly-avidin nucleus, i.e. nucleus formed from the self-assembling of tetrameric avidin units on oligonucleotide sequences of nucleic acids, on which biotinylated compounds are further auto-assembled through high-affinity interactions between the avidin of the central nucleus and the biotin of the biotinylated compounds. The biotinylated compounds are functionalized so as to bind drugs with a reversible bond, allowing the delivery thereof and a controlled release.

Claim (Index 23):
The method according to  claim 22 , wherein the inflammatory pathologies are selected from acute, chronic osteoarticular pathologies, and autoimmune pathologies.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.67797
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12667116', '13804602', '13352268', '12771495', '11787932']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.756491306111605
- 35 USC 102 Novelty (BERT): 0.5330023285902377
- Combined Prediction Score: 0.7341424083594682
- Mean Citation Score: 202.196084
- Max Citation Score: 329.49768
- Similarity Product: 168.51276783951758

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test